At a glance
- Originator Servier
- Class Vasoconstrictors
- Mechanism of Action Serotonin 2A receptor antagonists; Thromboxane A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 03 Nov 2003 No development reported - Preclinical for Thrombosis in France (unspecified route)
- 19 Sep 2001 New profile
- 19 Sep 2001 Preclinical development for Thrombosis in France (Unknown route)